Return on average equity - 5 year average | 3.69 |
Net Income/employee - trailing 12 month | 53,696.11 |
Revenue/employee - most recent fiscal year | - |
Return on investment - most recent fiscal year | 3.56 |
Return on average assets - most recent fiscal year | 2.74 |
Receivables turnover - most recent fiscal year | 13.93 |
Return on investment - trailing 12 month | - |
Return on average assets - trailing 12 month | - |
Inventory turnover - most recent fiscal year | 2.45 |
Inventory turnover - trailing 12 month | - |
Revenue/employee - trailing 12 month | 23,56,145.00 |
Return on average assets - 5 year average | 2.66 |
Net Income/employee - most recent fiscal year | - |
Return on average equity - trailing 12 month | - |
Receivables turnover - trailing 12 month | - |
Asset turnover - most recent fiscal year | 1.26 |
Asset turnover - trailing 12 month | - |
Return on average equity - most recent fiscal year | 3.66 |
Return on investment - 5 year average | 3.59 |
Sandu Pharmaceuticals Dividend Sandu Pharmaceuticals Bonus Sandu Pharmaceuticals News Sandu Pharmaceuticals AGM Sandu Pharmaceuticals Rights Sandu Pharmaceuticals Splits Sandu Pharmaceuticals Board Meetings Sandu Pharmaceuticals Shareholdings Sandu Pharmaceuticals Profit Loss Sandu Pharmaceuticals Balance Sheet Sandu Pharmaceuticals Cashflow Sandu Pharmaceuticals Q1 Results Sandu Pharmaceuticals Q2 Results Sandu Pharmaceuticals Q3 Results Sandu Pharmaceuticals Q4 Results
Top GainersTop LosersIndian IndicesBSE Active StocksNSE Active Stocks